Matches in SemOpenAlex for { <https://semopenalex.org/work/W4234546366> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4234546366 endingPage "508" @default.
- W4234546366 startingPage "498" @default.
- W4234546366 abstract "1α,25-dihydroxyvitamin D3 [1,25(OH)2D3] inhibits production of IL-12, a cytokine involved in the development of Th1 cells and in the pathogenesis of Th1-mediated autoimmune diseases. Here, we show that 1,25(OH)2D3 and a non-hypercalcemic analogue are selective and potent inhibitors of Th1 development in vitro and in vivo without inducing a deviation to the Th2 phenotype. Administration of 1,25(OH)2D3 or its analogue prevents chronic-relapsing experimental allergic encephalomyelitis (CR-EAE) induced by the myelin oligodendrocyte glycoprotein (MOG) peptide 35 – 55 (MOG35 – 55) in Biozzi AB / H mice. The inhibition of EAE induction is associated with a profound reduction of MOG35 – 55-specific proliferation and Th1 cell development. Importantly, the non-hypercalcemic analogue also provides long-term protection from EAE relapses induced by immunization with spinal cord homogenate when administered for a short time at symptom onset or even after the first peak of disease. Neuropathological analysis shows a reduction of inflammatory infiltrates, demyelinated areas and axonal loss in brains and spinal cords of treated mice. These resuls indicate that inhibition of IL-12-dependent Th1 cell development is associated with effective treatment of CR-EAE and suggest the feasibility of an approach based on low molecular weight inhibitors of IL-12 production in the treatment of multiple sclerosis." @default.
- W4234546366 created "2022-05-12" @default.
- W4234546366 creator A5012798385 @default.
- W4234546366 creator A5022588272 @default.
- W4234546366 creator A5035065505 @default.
- W4234546366 creator A5044514989 @default.
- W4234546366 creator A5055717009 @default.
- W4234546366 creator A5058458204 @default.
- W4234546366 creator A5059499088 @default.
- W4234546366 creator A5067863979 @default.
- W4234546366 creator A5087907628 @default.
- W4234546366 date "2000-02-01" @default.
- W4234546366 modified "2023-10-04" @default.
- W4234546366 title "Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3" @default.
- W4234546366 doi "https://doi.org/10.1002/1521-4141(200002)30:2<498::aid-immu498>3.3.co;2-h" @default.
- W4234546366 hasPublicationYear "2000" @default.
- W4234546366 type Work @default.
- W4234546366 citedByCount "2" @default.
- W4234546366 countsByYear W42345463662013 @default.
- W4234546366 crossrefType "journal-article" @default.
- W4234546366 hasAuthorship W4234546366A5012798385 @default.
- W4234546366 hasAuthorship W4234546366A5022588272 @default.
- W4234546366 hasAuthorship W4234546366A5035065505 @default.
- W4234546366 hasAuthorship W4234546366A5044514989 @default.
- W4234546366 hasAuthorship W4234546366A5055717009 @default.
- W4234546366 hasAuthorship W4234546366A5058458204 @default.
- W4234546366 hasAuthorship W4234546366A5059499088 @default.
- W4234546366 hasAuthorship W4234546366A5067863979 @default.
- W4234546366 hasAuthorship W4234546366A5087907628 @default.
- W4234546366 hasBestOaLocation W42345463661 @default.
- W4234546366 hasConcept C134018914 @default.
- W4234546366 hasConcept C150903083 @default.
- W4234546366 hasConcept C203014093 @default.
- W4234546366 hasConcept C207001950 @default.
- W4234546366 hasConcept C2776090121 @default.
- W4234546366 hasConcept C2776985911 @default.
- W4234546366 hasConcept C2777899865 @default.
- W4234546366 hasConcept C2778486448 @default.
- W4234546366 hasConcept C2778609137 @default.
- W4234546366 hasConcept C2778690821 @default.
- W4234546366 hasConcept C2779357208 @default.
- W4234546366 hasConcept C2780640218 @default.
- W4234546366 hasConcept C2780942790 @default.
- W4234546366 hasConcept C529278444 @default.
- W4234546366 hasConcept C86803240 @default.
- W4234546366 hasConcept C8891405 @default.
- W4234546366 hasConcept C98274493 @default.
- W4234546366 hasConceptScore W4234546366C134018914 @default.
- W4234546366 hasConceptScore W4234546366C150903083 @default.
- W4234546366 hasConceptScore W4234546366C203014093 @default.
- W4234546366 hasConceptScore W4234546366C207001950 @default.
- W4234546366 hasConceptScore W4234546366C2776090121 @default.
- W4234546366 hasConceptScore W4234546366C2776985911 @default.
- W4234546366 hasConceptScore W4234546366C2777899865 @default.
- W4234546366 hasConceptScore W4234546366C2778486448 @default.
- W4234546366 hasConceptScore W4234546366C2778609137 @default.
- W4234546366 hasConceptScore W4234546366C2778690821 @default.
- W4234546366 hasConceptScore W4234546366C2779357208 @default.
- W4234546366 hasConceptScore W4234546366C2780640218 @default.
- W4234546366 hasConceptScore W4234546366C2780942790 @default.
- W4234546366 hasConceptScore W4234546366C529278444 @default.
- W4234546366 hasConceptScore W4234546366C86803240 @default.
- W4234546366 hasConceptScore W4234546366C8891405 @default.
- W4234546366 hasConceptScore W4234546366C98274493 @default.
- W4234546366 hasIssue "2" @default.
- W4234546366 hasLocation W42345463661 @default.
- W4234546366 hasOpenAccess W4234546366 @default.
- W4234546366 hasPrimaryLocation W42345463661 @default.
- W4234546366 hasRelatedWork W144669723 @default.
- W4234546366 hasRelatedWork W1541403708 @default.
- W4234546366 hasRelatedWork W1957405565 @default.
- W4234546366 hasRelatedWork W2015637511 @default.
- W4234546366 hasRelatedWork W2131887019 @default.
- W4234546366 hasRelatedWork W2150616072 @default.
- W4234546366 hasRelatedWork W2774613711 @default.
- W4234546366 hasRelatedWork W2995289115 @default.
- W4234546366 hasRelatedWork W4205963569 @default.
- W4234546366 hasRelatedWork W2749200642 @default.
- W4234546366 hasVolume "30" @default.
- W4234546366 isParatext "false" @default.
- W4234546366 isRetracted "false" @default.
- W4234546366 workType "article" @default.